Answers are grounded in this paper and cite their sources.
Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.
No takes yet. Share an insight, caveat, or question.
Hegerova et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: